Ivermectin is safe for humans when prescribed by a doctor for its approved uses and taken at the correct dose. The FDA has approved oral ivermectin tablets for two parasitic infections, and topical forms are approved for head lice and rosacea. It has been on the World Health Organization’s List of Essential Medicines since 1987 and has been administered billions of times worldwide over more than 25 years.
That said, “safe” comes with important caveats. The dose matters enormously, the formulation matters, and what you’re taking it for matters. Here’s what you need to know.
What Ivermectin Is Approved to Treat
The FDA has approved ivermectin tablets for two specific parasitic conditions: intestinal strongyloidiasis (a roundworm infection) and onchocerciasis, commonly called river blindness. Both are caused by parasitic worms. Topical ivermectin is also approved for treating head lice and certain skin conditions like rosacea.
The World Health Organization has progressively expanded its list of approved uses over the decades. Ivermectin was first added to the WHO Essential Medicines List in 1987 for river blindness, then later for lymphatic filariasis, hookworm, other soil-transmitted worm infections, and scabies. In tropical regions, it is routinely given in mass drug administration campaigns, where millions of people receive it at once.
Why It’s Safe at the Right Dose
Ivermectin works by binding to specific ion channels found only in invertebrates, on the nerve and muscle cells of parasites. Once it locks onto these channels, it holds them open, flooding the cells with chloride ions. This paralyzes and kills the parasite. The key safety factor is selectivity: ivermectin has a much lower affinity for the equivalent channels in mammals. Your cells are largely unaffected at therapeutic doses, while the parasite’s nervous system shuts down.
This selective mechanism is why ivermectin has such a strong safety record when used correctly. Over 25 years of clinical experience, reviewed in the Journal of Drugs in Dermatology, supports its tolerability across a wide range of parasitic conditions.
Common Side Effects
At prescribed doses, most people tolerate ivermectin well. The most commonly reported side effects include joint pain, muscle stiffness, difficulty moving, and swollen or tender lymph nodes. These reactions are often related to the body’s inflammatory response as parasites die off rather than a direct toxic effect of the drug itself. If you’re being treated for a heavy parasite burden, you may experience more pronounced symptoms as the parasites break down.
Less common side effects include dizziness (especially when standing up), fever, chills, facial swelling, eye irritation, and tingling in the hands or feet. Rare but serious reactions can include confusion, seizures, loss of consciousness, and difficulty walking, though these are uncommon at standard doses.
Where the Danger Starts
The biggest safety risks come from two scenarios: taking too high a dose, or taking a product not made for humans.
Veterinary ivermectin products are formulated for animals that weigh far more than a person. A tube of horse paste, for example, contains concentrations intended for an animal weighing over 1,000 pounds. The FDA has explicitly warned that animal ivermectin products can cause serious harm in people, because the agency has only evaluated their safety for the specific animal species on the label. Beyond concentration differences, veterinary formulations may contain inactive ingredients that have never been tested for human safety.
Even with human-grade ivermectin, taking more than the prescribed amount increases the risk of serious neurological side effects, including confusion, difficulty walking, seizures, and loss of consciousness. The drug’s favorable safety profile depends entirely on staying within the therapeutic dose range.
Pregnancy and Breastfeeding
There is not enough evidence to confirm that ivermectin is safe during pregnancy. The FDA previously classified it as pregnancy category C, meaning animal studies showed adverse effects on the fetus, but no adequate human studies exist. In animals, those adverse outcomes appeared at doses 20 to 600 times the standard human dose, so the risk at normal therapeutic levels remains unclear. A systematic review published in The Lancet Global Health concluded that the evidence is simply insufficient to draw firm conclusions, and mass treatment campaigns actively try to avoid giving ivermectin to pregnant women.
If you’re pregnant, breastfeeding, or planning to become pregnant, this is a conversation to have with your prescriber before taking ivermectin for any reason.
Ivermectin and COVID-19
Much of the public interest in ivermectin safety stems from its proposed use against COVID-19. The FDA has been clear that ivermectin is not approved or authorized for treating or preventing COVID-19. While the drug showed some antiviral activity in lab settings, the concentrations needed were far higher than what the body achieves at safe doses. Large clinical trials failed to demonstrate a meaningful benefit for COVID-19 patients.
The surge in self-medication during the pandemic led to a spike in ivermectin poisonings, largely from people using veterinary products or taking excessive doses. This is the context behind many of the safety warnings you’ll find online: not that prescribed ivermectin is inherently dangerous, but that unsupervised use of the wrong product or dose can be.
Who Should Be Cautious
People with liver disease should use ivermectin carefully, since the drug is processed through the liver. Those with weakened immune systems or infections that affect the central nervous system (such as African trypanosomiasis or certain types of meningitis) face higher risks of serious neurological side effects. Ivermectin can also interact with other medications, particularly those processed by the same liver enzymes, potentially raising drug levels in the blood to unsafe concentrations.
Children weighing less than 15 kilograms (about 33 pounds) are generally not given ivermectin, as safety data in very young children is limited. For everyone else, the drug’s decades-long track record in mass treatment programs provides strong reassurance, provided it’s the right formulation at the right dose for a condition it actually treats.